Ontology highlight
ABSTRACT: Background
Anticipated success rates and timelines for COVID-19 vaccine development vary. Recent experience with developing and testing viral vaccine candidates can inform expectations regarding the development of safe and effective vaccines.Objective
To estimate timelines and probabilities of success for recent vaccine candidates.Design
ClinicalTrials.gov was searched to identify trials testing viral vaccines that had not advanced to phase 2 before 2005, and the progress of each vaccine from phase 1 through to U.S. Food and Drug Administration (FDA) licensure was tracked. Trial characteristics were double-coded. (Registration: Open Science Framework [https://osf.io/dmuzx/]).Setting
Trials launched between January 2005 and March 2020.Participants
Pre
SUBMITTER: MacPherson A
PROVIDER: S-EPMC7707230 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature